InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Lin Celia. Officer active across 1 company, notably Vera Therapeutics, Inc.. Aggregated, 2 filings have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €23k. History available since 19 August 2022. The latest transaction was disclosed on 21 August 2023 (Cession). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations